About Us
Founded in 2014 and located in the vibrant medtech ecosystem in Montpellier, France, Sim&Cure is a digital start-up focused on improving neurovascular treatments of cerebral aneurysm with a proprietary software suite (Class IIa medical device with CE mark and FDA 510k cleared) that has already been used to treat more than 4,000 patients in 300 hospitals.
Sim&Cure has won the prestigious i-Lab national context twice in 2014 and 2015 and i-Nov in 2020,
The start-up is backed by the Seed Fund IT-Translation and Elaia Partners
Sim&Cure has established scientific and clinical collaborations with leading laboratories and hospitals around the world.
The company employs 34 people and anticipates a phase of strong growth.